Poisoning with rice tablets (aluminum phosphide). Toxic effect of rodenticides
Conditions
Interventions
Intervention group: The dihydroxyacetone (DHA) serum for injection, which is prepared in 500 cc bottles of 5% dextrose water at Shiraz University of Medical Sciences, is given intravenously to the pat
Sponsors
Bojnourd University of Medical Sciences
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: This study is conducted on people who have been poisoned (intentionally or unintentionally) with aluminum phosphide (rice tablets).
Exclusion criteria
Exclusion criteria: The rice tablet(s) is/are exceeded their expiration date. The tablet(s) is/are exposed to moisture and release(s) its/their phosphine gas. The tablet(s) is/are dissolved in water prior to use and so release(s) its/their phosphine gas. The tablet(s) is/are thoroughly crushed before use, resulting in a large amount of phosphine gas being released. The tablet(s) and its/their contents are thrown out immediately after eating due to vomiting. The person ingested the "Banan tablet" (a tablet that contains garlic, salt and starch, and is sometimes erroneously referred to as the rice tablet in Iran).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in blood pressure. Timepoint: At predetermined intervals prior to and following the administration of DHA until the death or hospital discharge. Method of measurement: Blood pressure monitor.;Electrocardiogram (ECG) changes. Timepoint: At predetermined intervals prior to and following the administration of DHA until the death or hospital discharge. Method of measurement: Electrocardiography.;Contractile strength of the heart by measuring EF. Timepoint: At predetermined intervals prior to and following the administration of DHA until the death or hospital discharge. Method of measurement: Echocardiography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Arterial oxygen saturation. Timepoint: At predetermined intervals prior to and following the administration of DHA until the death or hospital discharge. Method of measurement: Measurement of arterial oxygen saturation.;Blood glucose. Timepoint: At predetermined intervals prior to and following the administration of DHA until the death or hospital discharge. Method of measurement: Laboratory measurement of blood glucose.;Level of consciousness. Timepoint: At predetermined intervals prior to and following the administration of DHA until the death or hospital discharge. Method of measurement: Using the Glasgow Coma Scale (GCS).;Mortality rate. Timepoint: End of the study. Method of measurement: Number of patients who died.;Incidence of adverse effects. Timepoint: During and following the administration of DHA until the death or hospital discharge. Method of measurement: Incidence of the adverse effect following DHA injection.;Arterial blood acidity. Timepoint: At predetermined intervals prior to and following the administration of DHA until the death or hospital discharge. Method of measurement: Measurement of arterial blood pH.;Heart rate. Timepoint: At predetermined intervals prior to and following the administration of DHA until the death or hospital discharge. Method of measurement: Heart rate monitor. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Bagher Oghazian
Bojnourd University of Medical Sciences
Outcome results
None listed